How many email patterns does Immunophotonics, Inc. use?

Immunophotonics, Inc. uses 1 known email pattern.

What domain does Immunophotonics, Inc. use for work emails?

Immunophotonics, Inc. uses immunophotonics.com for work email addresses.

Most Common Email Formats at Immunophotonics, Inc.

Immunophotonics, Inc.'s most common email format is First@immunophotonics.com (ex. John@immunophotonics.com), used for 100% of immunophotonics.com addresses. Immunophotonics, Inc. uses 1 email pattern.

@immunophotonics.com

1 pattern

Format	Example	Share of immunophotonics.com
First@immunophotonics.comMost common	John@immunophotonics.com	100%

Frequently Asked Questions

What does Immunophotonics, Inc. do?

Immunophotonics, Inc. was founded in 2012 and operates in the Pharmaceutical Manufacturing industry, alongside similar companies like Roche, sanofi and Johnson & Johnson. You can visit immunophotonics.com. Explore Immunophotonics, Inc.'s company overview page for more information.

What is Immunophotonics, Inc.'s email address format?

Immunophotonics, Inc.'s email format typically follows the pattern of First@immunophotonics.com; this email format is used 100% of the time. Looking for more contact data? Unlock accurate emails and phone numbers from millions of profiles verified in real-time.

How many employees does Immunophotonics, Inc. have currently?

Immunophotonics, Inc. has approximately 18 employees as of September 2026. Key team members to contact include Vice President Business Development (immunophotonics, Inc.) Managing Director (ips Biopharma Ag): T. V. and Non Executive Director: J. H. For more team information and contact data, explore Immunophotonics, Inc.'s employee directory with LeadIQ.

Immunophotonics, Inc. Email Format

Pharmaceutical ManufacturingMissouri, United States11-50 Employees

Immunophotonics, Inc. is a privately held, clinical-stage biotechnology company in the pharmaceutical manufacturing sector, based at 4340 Duncan Avenue, St. Louis, Missouri 63110, United States. It develops IP-001, a proprietary carbohydrate polymer intended to stimulate patient-specific anticancer immunity for solid tumors, with activation linked to a routine tumor ablation. The approach aims to enhance interactions between tumor antigens and the immune system and to promote the activity of tumor-infiltrating T cells, potentially supporting longer-term protective immunity. The company has pursued external partnerships, including collaborations with Johnson & Johnson and other innovation partners, and has secured venture financing such as a 2022 Series B. In September 2025, the company announced a leadership transition after the former CEO stepped down, with a new CEO and President to assume the roles.

Most Common Email Formats at Immunophotonics, Inc.

@immunophotonics.com

Need a specific person's email?

Frequently Asked Questions

What does Immunophotonics, Inc. do?

What is Immunophotonics, Inc.'s email address format?

How many employees does Immunophotonics, Inc. have currently?

Immunophotonics, Inc. Email Format

Ready to create more pipeline?

Everything for prospecting,
in one platform.

What you can expect from LeadIQ:

Ready to create more pipeline?

Most Common Email Formats at Immunophotonics, Inc.

@immunophotonics.com

Need a specific person's email?

Frequently Asked Questions

What does Immunophotonics, Inc. do?

What is Immunophotonics, Inc.'s email address format?

How many employees does Immunophotonics, Inc. have currently?

Immunophotonics, Inc. Email Format

Ready to create more pipeline?

Everything for prospecting,in one platform.

What you can expect from LeadIQ:

Ready to create more pipeline?

Everything for prospecting,
in one platform.